Deferoxamine Injection, Powder, Lyophilized, For Solution
Product Images NDC 63323-597

Product Visual Gallery

This gallery contains 6 technical images submitted to the FDA as part of the official labeling for Deferoxamine (NDC 63323-597). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Fresenius Kabi Usa, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Deferoxamine Structure

Chemical structure diagram of deferoxamine mesylate, showing its molecular formula with atomic connections and a molecular weight of 656.79.*

FDA Label Image

Logo (Fk17 Address)

Deferoxamine 95 mg/mL injection powder, lyophilized, for solution. The packaging is white with the Fresenius Kabi logo in black on the upper left and the text 'Fresenius Kabi USA, LLC' at the bottom. The label indicates it is manufactured in Lake Zurich, IL 60047.*

FDA Label Image

Pbox (Pbox)

Deferoxamine Mesylate for Injection, USP, 500 mg per vial lyophilized powder for solution by Fresenius Kabi USA, LLC. The label indicates use for subcutaneous, intramuscular, or intravenous administration.*

FDA Label Image

Pbox (Pbox2)

Label for Deferoxamine Mesylate for Injection, USP, indicating a strength of 2 grams per vial. The label states the drug is for subcutaneous, intramuscular, or intravenous use, is prescription only, and for single use. It includes the Fresenius Kabi logo at the bottom.*

FDA Label Image

Vial (Vial)

Deferoxamine Mesylate 500 mg per vial injection powder label for solution. The label indicates use for subcutaneous, intramuscular, or intravenous administration and specifies Rx only. The design includes a red and light blue color scheme. Labeler is not shown on the visible part of the label.*

FDA Label Image

Vial (Vial2)

Label from Deferoxamine Mesylate Injection, USP showing strength of 2 grams per vial. The label indicates the product is for subcutaneous, intramuscular, or intravenous use. It specifies single use only and is prescription use only.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.